| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/21/2005 | WO2005034903A1 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer |
| 04/21/2005 | WO2005034878A2 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085635 Method of mycophenolate mofetil preparation |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085534 Reacting 5-halophthalane with cyanide compound in suitable solvent |
| 04/21/2005 | US20050085533 Central nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 04/21/2005 | US20050085516 2-W-diaminocarboxylic acid compounds |
| 04/21/2005 | US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085504 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products |
| 04/21/2005 | US20050081310 violet to dark-blue oxidative hari dyes with high intensity, stability, and water stability; color, light, wash, and rubbing fastness, storage stability |
| 04/21/2005 | CA2549931A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 04/21/2005 | CA2542077A1 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP1524255A1 Polyalkylbicyclic derivatives |
| 04/20/2005 | EP1523477A1 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid |
| 04/20/2005 | EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 04/20/2005 | EP1470118B1 Alpha-methylenelactone synthesis in supercritical fluids |
| 04/20/2005 | EP1299073B1 Agents for colouring keratin fibres, containing derivatives of benzo(b)furane-3-one and/or benzo(b)thiophene-3-one |
| 04/20/2005 | EP1173400A4 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | EP0949919B1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 04/20/2005 | CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608057A Method for the preparation of citalopram |
| 04/20/2005 | CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1197853C Method for producing maleic acid anhydride |
| 04/20/2005 | CN1197852C High molecular monomer of chemical amplification type light resistance agent compson. |
| 04/19/2005 | US6881874 Process for the catalytic oxidation of hydrocarbons |
| 04/19/2005 | US6881851 Preparation of tetrahydro-3-furoic acid |
| 04/19/2005 | US6881846 Antiproliferative agents |
| 04/19/2005 | CA2333199C Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof |
| 04/14/2005 | WO2005033090A1 Aromatic compound |
| 04/14/2005 | WO2005033089A1 Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide |
| 04/14/2005 | WO2005033065A1 Novel amidine compounds for treating microbial infections |
| 04/14/2005 | WO2005033060A1 Method for producing ester condensed product |
| 04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 04/14/2005 | WO2004110348A3 Saururus cernuus compounds that inhibit cellular responses to hypoxia |
| 04/14/2005 | US20050080299 Method for the preparation of matairesinol |
| 04/14/2005 | US20050080278 Using 5-phthalancarbon nitrile as chemical intermediate; antidepressants |
| 04/14/2005 | US20050080276 Process for producing lactone |
| 04/14/2005 | US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080130 Compounds foriImaging alzheimer's disease |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080115 Novel compounds, their preparation and use |
| 04/14/2005 | US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation |
| 04/14/2005 | CA2537791A1 Novel amidine compounds for treating microbial infections |
| 04/13/2005 | EP1522539A1 Crystalline composition containing escitalopram |
| 04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |
| 04/13/2005 | CN1606551A Substituted 2-phenyl benzofurans as estrogenic agents |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1606543A Alpha-cyanoacrylates |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1605587A Fluoro-aromatic organic tetracarboxylic dianhydride and its preparation method and use |
| 04/13/2005 | CN1605584A High active thermo-crosslinking acid decomposable compound and its synthesis process |
| 04/13/2005 | CN1605336A Application of L-butylphthalide in the process for preparing cerebral infarction preventing and treating medicine |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196464C Novel coloring agent for use in oxidative hair dyeing |
| 04/12/2005 | US6878834 Selectively reduced to the corresponding hydroxy group |
| 04/12/2005 | US6878831 Optical resolution |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878745 Selective preventives/remedies for progressive lesions after organ damage |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878742 Alzheimer's disease; Down's syndrome |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030830A1 Multifunctional monomers containing bound poragens and polyarylene compositions therefrom |
| 04/07/2005 | WO2005030748A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 04/07/2005 | WO2005030747A1 A process for the synthesis of 3-hydroxy-gamma-butyrolactone |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030702A1 Biphenyloxy-acids |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030199A1 4-(1-benzofuran-3-yl-methylideneaminoxy.propoxy))-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis |
| 04/07/2005 | WO2005030198A1 Medicinal composition for treatment for fatty liver or liver disease |
| 04/07/2005 | WO2005014565A3 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof |
| 04/07/2005 | WO2004098283A3 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050075316 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmai agents; anticancer agents; astaxanthin |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539250A1 Biphenyloxy-acids |